glp-1 agonists uses Agonists: A Comprehensive Overview ๐ง๐ต๐ฒ ๐๐ณ๐ณ๐ฒ๐ฐ๐ ๐ผ๐ณ ๐๐๐ฃ-๐ญ ๐ฅ๐ฒ๐ฐ๐ฒ๐ฝ๐๐ผ๐ฟ
Description
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
These surgeries were lengthy, required large incisions and often caused complications
doi: 10.1007/s10557-019-06915-8 90 VermaMKGoelRKrishnadasNNemmaniKVS
Ther Adv Endocrinol Metab (2021) 12:2042018821989238
Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes
